Flow cytometric analysis revealed significantly higher NOTCH1 activation in CD34+/CD38− and CD34+/CD38+ cells from CLL patients, regardless NOTCH1 mutation compared to healthy donors. The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.